E-BOOK: Ocular Cell and Gene Therapy Preclinical Reference Guide

This e-book aims to overview cell and gene therapies for ocular diseases from a preclinical drug development perspective. We provide descriptions of best practices in the use of  suitable test systems and key evaluation parameters for ophthalmic preclinical development, as well as guiding principles for regulatory submission. Finally, we discuss our view about how the sector is likely to evolve in the coming decade.

Are you prepared for the preclinical challenges involved in developing gene therapies of the eye?